Astremiha Therapeutics
PrivateLast Round
Early Funding
Jul 1, 2026
Total Funding Raised
$1,126
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Astremiha Therapeutics operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Seed round in January 2026.
Astremiha Therapeutics is a biotechnology company developing broad-spectrum, host-directed antivirals designed to block viral replication and strengthen the immune system to combat chronic viral infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Astremiha Therapeutics Comparables
Compare Astremiha Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Meletios Therapeutics | 83% | |
| Evrys Bio | 77% | |
| Kimer Med | 77% |
For institutional investors. Book with your work email.
Astremiha Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 1, 2026 | ||||
| Seed | Jan 15, 2026 |
For institutional investors. Book with your work email.
Astremiha Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paris Biotech Santé | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Raised $2.85M in early funding.
- Jan 15, 2026
$1K Seed round completed.
For institutional investors. Book with your work email.
Astremiha Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Astremiha Therapeutics's valuation, stock price, and market status.
Is Astremiha Therapeutics a public or private company?
Astremiha Therapeutics is a private company.
What is the current stock price of Astremiha Therapeutics?
Astremiha Therapeutics is a private company, so its shares have no public market price. Caplight tracks Astremiha Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Astremiha Therapeutics worth (valuation)?
Valuation information for Astremiha Therapeutics is not publicly available.
Can I buy Astremiha Therapeutics stock?
Astremiha Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Astremiha Therapeutics's last funding round?
Astremiha Therapeutics's most recent funding round was Early Funding on July 1, 2026.
Who are the main investors in Astremiha Therapeutics?
Key investors in Astremiha Therapeutics include Paris Biotech Santé.
Will Astremiha Therapeutics IPO soon?
No public IPO plans have been announced for Astremiha Therapeutics.
How can I track Astremiha Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Astremiha Therapeutics's shares on secondary markets.